Company Description
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care, based on total net sales of med-surg products.
We deliver mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities.
Through our two segments, Medline Brand and Supply Chain Solutions, we offer approximately 335,000 med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products.
We hold the leading position across several of our end markets and many of our key product families. We distribute these products through our expansive network of 69 global distribution facilities, spanning over 29 million square feet of warehouse space, and our owned fleet of over 2,000 MedTrans trucks, enabling us to provide next-day delivery to 95% of our U.S. customers.
| Country | United States |
| Founded | 1966 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 43,000 |
| CEO | James Boyle |
Contact Details
Address: 3 Lakes Drive Northfield, IL 60093 United States | |
| Phone | (847) 949-5500 |
| Website | medline.com |
Stock Details
| Ticker Symbol | MDLN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002046386 |
| Employer ID | 33-1845288 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| James M. Boyle | Chief Executive Officer and Director |
| James M. Pigott | President |
| Michael B. Drazin | Chief Financial Officer |
| Stephen L. Miller | Chief Operating Officer |
| Alex M. Liberman | Chief Legal Officer |
| Douglas P. Golwas | Chief Commercial Officer |
| Christopher P. Shryock | Chief Human Resources Officer |
| Amanda H. Laabs | Chief Product Officer |
| William J. Abrams | Executive Vice President, Supply Chain Solutions |
| Charles N. Mills | Chair of the Board of Directors |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 4, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Oct 28, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Aug 15, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Mar 19, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Feb 28, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jan 31, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Dec 19, 2024 | DRS | [Cover] Draft Registration Statement |